After-Hours Gains For Phathom (PHAT) On Regulatory Approval
Fahim Awan
November 2, 2023
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) extended its surge in post-market trading on Wednesday, registering a remarkable 5.62% increase, reaching $10.15. During the standard trading session,